We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Renal Cell Carcinoma

Journal Scan / Research · January 13, 2021

Obesity Diminishes Response to PD-1–Based Immunotherapies in Renal Cancer

Journal for immunotherapy of cancer


Additional Info

Disclosure statements are available on the authors' profiles:

Journal for immunotherapy of cancer
Obesity Diminishes Response to PD-1-Based Immunotherapies in Renal Cancer
J Immunother Cancer 2020 Dec 22;8(xx)e000725, SK Boi, RM Orlandella, JT Gibson, et al

Further Reading